Akèy › Limfòm Burkitt › Colorado › Aurora

Etid klinik pou Limfòm Burkitt nan Aurora, CO

10 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Aurora (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2

Children's Hospital Colorado, Aurora

366 Days – 46 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT06124157

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Ap rekriteEtid obsèvasyon

Children's Hospital Colorado, Aurora

Laj 0 a 38 · Tout sèks · Mizajou Oct 1, 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Ap rekriteFaz 2

Children's Hospital Colorado, Aurora

365 Days · Tout sèks · Mizajou Sep 25, 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora

6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Ap rekriteFaz 1/2

Children's Hospital Colorado, Aurora

31 Days – 30 Years · Tout sèks · Mizajou Sep 14, 2026 · NCT04544592

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Ap rekriteFaz 2

Children's Hospital Colorado, Aurora

Laj 1 a 30 · Tout sèks · Mizajou Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Ap rekriteFaz 3

Children's Hospital Colorado, Aurora

365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL

Ap rekriteFaz 1

Children's Hospital Colorado, Aurora

3 Months – 30 Years · Tout sèks · Mizajou Nov 28, 2025 · NCT06559189

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Ap rekriteFaz 1/2

University of Colorado - Aurora Cancer Center, Aurora

Laj 15 a 50 · Tout sèks · Mizajou Sep 9, 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Ap rekriteFaz 2

Children's Hospital Colorado, Aurora

Laj 1 a 25 · Tout sèks · Mizajou May 4, 2025 · NCT03509961

Etid Limfòm Burkitt nan lòt vil

Lòt etid nan Aurora

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.